DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo

BioTime, Inc.

NYSEMKT: BTX

2.73 0.01 (0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BTX $2.73 0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.73
Previous Close $2.72
Daily Range $2.60 - $2.79
52-Week Range $2.59 - $4.82
Market Cap $190.0M
P/E Ratio -3.36
Dividend (Yield) $0.00 (0.0%)
Volume 191,365
Average Daily Volume 247,694
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

BioTime, Inc. (BTX) Description

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use. Website: http://www.biotimeinc.com/

News & Commentary

Advanced Cell Technology: A Key Patent Critique

BioTime Joins Advanced Cell Technology In The AMD Race

Osiris Therapeutics: Poised For Another Breakout

5 Stocks With Big Insider Buying

Stocks: Insiders Buy at Titan International, Cytokinetics, and BioTime

Plus, a purchase at Clearfield.

5 Stocks Insiders Love Right Now

Insiders Buy Shares at BioTime, TechTarget, and Accelrys

OFG Bancorp also sees a purchase.

Top Insider Trades: BTX TTGT OFG ACCL

Is Geron Finally Onto Something?

Here's why biotech Geron is a prime buyout target.

3 Reasons Behind Geron's Rebound

Let’s take a look at three reasons Geron bounced back more than 200% in 2013, and how its industry peers -- Celgene, Novartis, and Incyte -- have been affected.

See More BTX News...

BTX's Top Competitors

BTX $2.73 (0.37%)
Current stock: BTX
AMGN $115.54 (0.47%)
Current stock: AMGN
GILD $69.28 (1.63%)
Current stock: GILD
BIIB $291.48 (2.10%)
Current stock: BIIB